Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Radiation, Pemetrexed, and Carboplatin for Locally Advanced Esophageal Cancer
NCT00268437Phase 2Terminated
- Sponsor
- Cancer and Leukemia Group B
- Start
- Apr 2006
- Primary completion
- Jan 2008
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pemetrexed and carboplatin in esophageal cancer, sponsored by Cancer and Leukemia Group B. Primary endpoint: Pathologic Complete Response Rate. Started Apr 2006; status: terminated.
02
Drugs
pemetrexedcarboplatin
03
Conditions
esophageal cancer
Beyond the preview
Go deeper on NCT00268437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00268437.